The findings of a pilot study has found that depressed patients, who suffered from COVID respond better to standard antidepressants than people who haven't had COVID.
The findings of a new study led by UCL researchers suggest that when people stop taking antidepressants after a long period of use, just over half (56 percent) experience a relapse within a year, compared to 39 percent of those who stay on medication.
